Camp4 director awarded options for 28,000 shares
Camp4 Therapeutics director and 10% owner Andrew J. Schwab reported receiving a grant of stock options representing 28,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Camp4 Therapeutics director and 10% owner Andrew J. Schwab reported receiving a grant of stock options representing 28,000 shares of common stock. The options have an exercise price of $4.34 per share and expire on June 9, 2036. According to the footnote, all shares underlying the option vest on the earlier of the first anniversary of the grant date or the issuer's next annual stockholder meeting, contingent on continued service. After this grant, Schwab holds 28,000 options directly.
Insider Trade Summary
Grant/Award: 28,000 shares
Grant/Award
1 txn
Insider
Schwab Andrew J.
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.
Key Figures
Options granted: 28,000 options
Exercise price: $4.34 per share
Expiration date: June 9, 2036
+2 more
5 metrics
Options granted
28,000 options
Stock Option (Right to Buy) grant to Andrew J. Schwab
Exercise price
$4.34 per share
Conversion or exercise price of granted options
Expiration date
June 9, 2036
Option expiration for Schwab’s 28,000 options
Underlying shares
28,000 shares
Common Stock underlying the option grant
Post-grant derivative holdings
28,000 options
Total options held following the reported transaction
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "4.3400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-09T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"The shares underlying the option vest in their entirety on the earlier of the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Camp4 Therapeutics (CAMP) report for Andrew J. Schwab?
Camp4 Therapeutics reported that director and 10% owner Andrew J. Schwab received a grant of stock options for 28,000 shares of common stock. These options were awarded at an exercise price of $4.34 per share and are held directly by him.
What are the key terms of Andrew J. Schwab’s Camp4 Therapeutics stock option grant?
Andrew J. Schwab was granted options covering 28,000 Camp4 Therapeutics common shares at a $4.34 exercise price. The options expire on June 9, 2036, giving him the right to buy shares at that price until the expiration date.
When do Andrew J. Schwab’s Camp4 Therapeutics stock options vest?
All shares underlying the option vest in full on the earlier of the first anniversary of the grant date or Camp4 Therapeutics’ next annual stockholder meeting. Vesting is conditioned on Schwab’s continued service to the company through the applicable vesting date.
How many Camp4 Therapeutics options does Andrew J. Schwab hold after this transaction?
Following this grant, Andrew J. Schwab holds 28,000 stock options in Camp4 Therapeutics. The Form 4 shows this as his total derivative holdings related to this specific award, with the options exercisable into an equal number of common shares once vested.
Is Andrew J. Schwab’s Camp4 Therapeutics option grant a market purchase or a compensation award?
The transaction is classified as a grant or award acquisition, not an open-market purchase. Schwab did not pay for the options at grant; instead, he received them as compensation with a $4.34 per share exercise price payable upon future exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates